转变生长因子,β-2基因突变导致自体主导的卡穆拉蒂-恩格尔曼病,类型2 (OMIM % 606631)
Steven Mumm1, José L Paz-Ibarra2, Philippe M Campeau3
1Division of Bone and Mineral Diseases, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO 63110, USA; Center for Metabolic Bone Disease and Molecular Research, Shriners Hospitals for Children-St. Louis, St. Louis, MO 63110, USA.
Bone
|April 9, 2025
概括
卡穆拉蒂-恩格尔曼病2型 (CED2) 是一种罕见的骨发育不良. 在一家秘鲁人中发现了一种导致CED2的新型TGFB2基因突变,呈现为痛苦的超静止症.
科学领域:
- 遗传学 是一个遗传学.
- 骨发育不良症 骨发育不良症
- 分子生物学分子生物学
背景情况:
- 卡穆拉蒂-恩格尔曼病1型 (CED1) 是一种由TGFB1突变引起的自体主导骨发育不良.
- 由于负TGFB1分析,人们怀疑CED的遗传异质性,导致CED2.2的指定.
- 以前的报道表明,TGFB2突变在零星的CED2病例中发生.
研究的目的:
- 在一个秘鲁家庭中调查卡穆拉蒂-恩格尔曼病2型 (CED2) 的遗传基础.
- 识别和描述与CED2表型相关的新型遗传变异.
主要方法:
- 整体外体序列或TGFB2.2的向基因序列.
- 在受影响的家庭内进行隔离分析.
- 对已识别的变种进行生物信息分析 (例如,Polyphen-2,SIFT,gnomAD).
- 使用ACMG指南评估变种病原性.
主要成果:
- 在一个患有CED2.2的秘鲁家庭中,在TGFB2延迟相关 (LAP) 域中发现了一种新的误解变异 (c.108G>T,p.R36S).
- 这种变异在三代中与自体主导的CED2表型共分离.
- 已识别的TGFB2变种位于保存域中,在gnomAD中不存在,预计具有破坏性,并且与已知的致病变种相同.
结论:
- 新型TGFB2变种 (p.R36S) 很可能是致病性,并导致CED2.2.
- 这一发现扩大了卡穆拉蒂-恩格尔曼病的遗传谱.
- 氨基双酸盐治疗可能有助于控制CED2症状.
相关概念视频
The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K
Mutations
77.4K
Overview
77.4K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Translation
14.2K
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
Translation Produces the Building Blocks of Life
Proteins are...
14.2K
Immunoglobulin-like Cell Adhesion Molecules
3.2K
Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...
3.2K
Gene Conversion
9.6K
Other than maintaining genome stability via DNA repair, homologous recombination plays an important role in diversifying the genome. In fact, the recombination of sequences forms the molecular basis of genomic evolution. Random and non-random permutations of genomic sequences create a library of new amalgamated sequences. These newly formed genomes can determine the fitness and survival of cells. In bacteria, homologous and non-homologous types of recombination lead to the evolution of new...
9.6K


